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Abstract 
Mitochondrial dysfunction, such as reductions in ATP production via oxidative 
phosphorylation, is a recognized pathological symptom of neurodegenerative diseases 
including Alzheimer's disease (AD). One of the known risk factors for the development 
of AD is the inheritance of a specific genotype of a lipid transporting protein known as 
apolipoprotein E (apoE). How apoE contributes to the development and progression of 
AD is poorly understood. The purpose of this study was to determine if a relationship 
exists between mitochondrial dysfunction and genetic predisposition to AD via apoE. 
Mitochondrial bioenergetics and enzymatic activity were investigated in an AD mouse 
model (apoE KO) and in wild-type (WT) mice. Since AD develops with age, 
mitochondrial function was studied in both young (4-6 months old) and old (12-22 
months old) mice. Additionally, estrogen therapy was utilized as a possible therapeutic to 
prevent mitochondrial dysfunction. 
We isolated mitochondria located in nerve cell terminals (synaptosomes) using 
Percoll gradient centrifugation from WT (C57BL/6J) and apoE KO (Apoetn!Unc) mice. 
Mitochondria were isolated from the following three treatment groups: mice possessing 
ovaries injected with vehicle control solution (Sham), ovariectomized mice with vehicle 
control injection (OVX), and ovariectomized mice with 50 ng/g injection of 17~-estradiol 
(OVX + E2). Mitochondrial function was evaluated based on oxygen consumption of 
permeabilized and non-permeabilized synaptosomes and was measured using the 
OROBOROS Oxygraph-2k at 37°C. Succinate dehydrogenase (SDH) and citrate 
synthase (CS) activity was also assayed to help elucidate the bioenergetic profile of the 
isolated synaptosomes. 
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Our results revealed no significant differences in oxygen consumption from intact 
and permeabilized synaptosomes between Sham and OVX young WT and apoE KO 
mice. Additionally, no significant differences were detected in SDH and CS activity 
between young WT and apoE KO mice. However, estrogen treatment dramatically 
increased oxygen consumption and enzymatic activity in apoE KO for all respiration 
parameters, whereas, a minimal effect was observed in WT mice. No significant 
differences in oxygen consumption from permeabilized and intact synaptosomes were 
detected between young and old OVX and OVX + E2 treated mice, but old Sham mice 
had significantly higher oxygen consumption rates compared to young Sham mice for 
most all permeabilized parameters in both WT and apoE KO mice. Estrogen treatment 
had no effect on mitochondrial respiration in old mice, but estrogen treated old apoE KO 
mice had significantly higher SDH activity compared to its Sham. 
Increases in respiration and enzymatic activity prompted investigation of 
mitochondrial quantity via Western blot. We used the voltage dependent-anion-channel 
(VDAC) as a mitochondrial quantity marker. The results revealed that estrogen treatment 
increased mitochondrial quantity in estrogen treated young apoE KO and old Sham mice. 
We speculate that increases in mitochondrial quantity in young apoE KO mice and old 
Sham mice were due to estrogen and reactive oxygen species (ROS) induced 
mitochondrial biogenesis, respectively. Our data suggests that predisposition of AD via 
apoE inheritance is not an underlying source of mitochondrial abnormalities; however, 
the effectiveness of estrogen as a neuro-therapeutic may be dependent upon an 
individual's apoE genotype, as well as, their age. 
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I. Introduction 
A. The Role of the Mitochondrion in Alzheimer's Disease 
According to the Centers for Disease Control and Prevention, nearly 16 million 
Americans will be diagnosed with Alzheimer's disease (AD) by the year 2050. By this 
time, patient care cost associated with AD is expected to reach $1.2 trillion, which will 
confer an impressive economic burden on society. AD is characterized by the presence of 
neurofibrillary tangles and extracellular amyloid-P (AP) deposition (Selkoe, 1999), but 
the earliest detectable neuropathological hallmark of AD is decreased cerebral 
metabolism (Blass, 2000; Devi et al., 2006). It has long been known that reductions in 
mitochondrial enzymatic activity, including cytochrome c oxidase and a-ketoglutarate 
dehydrogenase, as well as, pyruvate dehydrogenase, occur during the pathological 
progression of AD and can be identified in postmortem whole-brain tissue samples from 
AD patients (Parker et al., 1989; Gibson et al., 1998; Sorbi et al., 1983). Interestingly, 
deficits in these key metabolic enzymes have been observed prior to the onset of AD 
pathology in animal models (Yao et al., 2009). A large body of evidence suggests that 
alterations in enzymatic activity observed in AD are a result of oxidative damage due to 
mitochondrial dysfunction (Hirai et al., 2001; Nunomura et al., 2001 ), but the exact 
mechanism leading to mitochondrial dysfunction specific to AD is unknown (Devi et al., 
2006). 
B. The Role of ApoE in Alzheimer's Disease 
One of the known risk factors for AD is the inheritance of a specific genotype of a 
lipid transporting protein known as apolipoprotein E (apoE). ApoE is a plasma protein 
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that is mainly expressed in the brain and liver (Elshourbagy et al., 1985). The gene for 
apoE is found on chromosome 19 and there have been three human isoforms identified: 
apm:2, apoc3, and apmA (Strittmatter et al., 1993). Specifically, the inheritance of the 
apmA allele markedly increases the incidence of AD (Strittmatter et al., 1994). Recent 
research suggests that the higher risk of developing AD, due to apor4 inheritance, is 
attributed to competitive binding of AP and apoE4-AP complexes to low-density 
lipoprotein receptor-related protein l(LRPl) and very-low-density lipoprotein receptor 
(VLDL) (Verghese et al., 2012; Schmechel et al., 1993; Deane et al., 2004). LRPl 
rapidly clears AP across the blood brain barrier (Bell et al., 2007; Shibata et al., 2000); 
however, apoE4 has been shown to bind with Ap, which shifts the clearance from an 
LRPl-mediated action to a much slower clearing mechanism mediated by VLDL, which 
drastically increases brain retention of AP (Deane et al., 2008). Higher concentrations of 
cellular Ap, due to decreased clearance, allows for the accumulation in organelles 
including the mitochondrion, which, along with increased ROS production, alters 
mitochondrial respiration (Hansson et al., 2004; Caspersen et al., 2005; Manczak et al., 
2006). 
As mentioned previously, reduced cerebral metabolism, as a result of a shift from 
glucose utilization to ketone bodies (Ishii et al., 1997), and altered mitochondrial 
respiration, due to reductions in mitochondrial enzymes (Yao et al., 2009; Hansson et al., 
2004; Caspersen et al., 2005; Manczak et al., 2006), are the earliest detectable symptoms 
of AD. Furthermore, previous studies have linked dysfunctional mitochondria, like those 
observed prior to the onset of AD pathology, with increased ROS production and 
oxidative stress, which exacerbate the progression of AD pathology (Khan et al., 2000; 
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Swerdlow et al., 1997; Cardoso et al., 2004). Therefore a reasonable approach for 
slowing the progression of AD would be a therapeutic molecule that combats 
mitochondrial dysfunction and subsequent ROS production in an attempt to prevent the 
occurrence of A~ and neurofibrillary tangles. 
C. Estrogen as a Potential Therapeutic in Alzheimer's Disease 
The female sex hormone, 17~-estradiol, is a lipophillic molecule that is able to 
cross the blood brain barrier and is synthesized from cholesterol de novo in the brain 
(Srivastava et al., 2011). In addition, previous studies have shown that mitochondria 
possess estrogen receptors (Yang et al., 2003; Chen et al., 2004), which have been shown 
to increase both the energetic efficiency of neurons and the antioxidant defense system 
for ROS elimination (Wang et al., 2001; Green and Simpkins, 2000). The properties of 
estrogen and its actions on the mitochondrion serves as a possible therapeutic compound 
for restoring the bioenergetic properties of dysfunctional mitochondria observed prior to 
the onset of AD pathology. 
D. Thesis Objectives 
Many studies have investigated the indirect effects of apoE on mitochondrial 
function, and its association with AD; however, a comprehensive investigation of the 
effects of apoE on mitochondrial bioenergetics is missing. The purpose of this study was 
to characterize the presence and absence of apoE and its effects on the bioenergetic 
properties of the nerve cell terminals, known as synaptosomes, using apoE knock out 
(KO) and wild type (WT) mice. Since AD is an age-related neurodegenerative disease we 
also investigated the impacts of aging on mitochondrial respiration, as well as, on the 
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activity of two key mitochondrial enzymes: citrate synthase and succinate 
dehydrogenase. We hypothesize treatment of estrogen will enhance mitochondrial 
performance with respect to age and genotype. Furthermore, we speculate that 
interventions aimed at reducing mitochondrial dysfunction in the early stages of AD 
development may slow or prevent progression of the disease. 
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II. Materials and Methods 
A. Chemicals 
Chemicals, reagents and consumables were supplied by Fisher Scientific, 
Pittsburgh, PA and Sigma-Aldrich, St. Louis, MO. Percoll was obtained from GE 
Healthcare, Buckinghamshire, UK. Female ApoetmJUnc gene deficient/knockout (apoE 
KO) and C57BL/6J wild-type (WT) littermate mice were purchased from The Jackson 
Laboratories (Bar Harbor, Maine). 
B. Surgeries 
Young (3-6 months) and old (12+ months) female apoE KO (ApoetmJUnc) and WT 
(C57BL/6J) littermate mice were used in this study. Mice were anesthetized with 1 µL 
ketamine/xylazine per 1 g body weight. After deep anesthesia was observed, the mouse 
was shaved and swabbed with 100% ethanol just below the last rib. A midline incision 
was made to expose the peritoneal cavity. The ovaries were identified and an incision 
between the beginning of the oviduct and ovary was made. The wound was sutured and 
sealed with surgical glue. All mice underwent surgery; however, sham mice were left 
with intact ovaries. Mice were given two weeks to recuperate from ovariectomy and 
sham surgeries. Mice were divided into the 12 experimental groups: (1) young WT sham, 
(2) young WT ovariectomized control (ovx ctrl), (3) young WT estrogen (E2), (4) old 
WT sham, (5) old WT ovx ctrl, (6) old WT E2, (7) young apoE KO sham, (8) young 
apoE KO ovx ctrl, (9) young apoE E2, (10) old apoE KO sham, (11) old apoE KO ovx 
ctrl, and (12) old apoE KO E2. After recuperation, both sham and ovx ctrl mice were 
administered an intraperitoneal (i.p.) injection of a com oil solution containing 1 % 
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ethanol, whereas, the E2 mice were given an i.p. injection of 50 ng/g body weight of 17P-
estradiol 24 h prior to sacrificing. 
C. Synaptosome Isolation 
Brain synaptosomes were isolated as described previously with minor 
modifications (Kristian, 2010). Briefly, synaptosomes were isolated 24 h post-treatment 
from all groups. The forebrain was removed, washed, and homogenized in 20 mL of 
isolation medium (IM) containing sucrose (225 mM), mannitol (75 mM), EGTA (1 mM), 
HEPES (5 mM), and 1 g/L BSA adjusted to pH 7.4 with Tris base. The homogenate was 
transferred evenly into two 10 mL polycarbonate tubes and centrifuged at 1300g for 3 
min. The pellet was resuspended in 3 mL ofIM and centrifuged at 1300g for an 
additional 3 min. The supernatants from the two centrifugations were combined and 
centrifuged at 21,000g for 10 min. A Percoll gradient in IM was prepared in a separate 
polycarbonate tube by first adding 3.7 mL of24% Percoll and, using a transfer pipette, 
1.5 mL of 40% Percoll was slowly added underneath the 24% Percoll layer. The 
supernatant from the previous centrifugation step was discarded and the pellet was 
resuspended in 3.5 mL of 15% Percoll, and the resuspended pellet was next layered on 
top of the 24/40% Percoll gradient using a transfer pipette, and then centrifuged at 
30, 700g for 8 min. The material at the 15% Percoll band, containing mostly myelin, was 
discarded, whereas the 24% Percoll band, containing mostly synaptic mitochondria, was 
collected. The fraction containing the synaptosomes was washed with 6 mL of IM and 
centrifuged at 16, 700g for 10 min. This step was repeated and the supernatant was 
discarded both times. The resulting pellet was resuspended in 400 µL of IM and 
contained 6-7mg/mL synaptosomal protein, which was determined using a Modified 
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Lowry Protein Assay Kit according to the instructions of the manufacturer (Thermo 
Fisher Scientific, Waltham, MA). 
D. Intact Synaptosome Respirometry 
Oxygen consumption of synaptosomes was measured in 2 mL of incubation 
medium (120 mM NaCl, 15 mM glucose, 3.5 mM KCl, 2 mM MgS04, 1.3 mM CaCh, 
1.2 mM Na2S04, 0.4 mM KH2P04) at 37°C using Clark-type polarographic electrodes. 
Mitochondrial bioenergetics of intact synaptosomes was evaluated in all treatment groups 
under the same set of conditions. Basal respiration was measured after the addition of 
synaptosomes to the incubation medium containing respiratory chamber. Under these 
conditions mitochondrial respiration was fueled by NADH and F ADH2 generated from 
the TCA cycle after decarboxylation of pyruvate, which was produced in the cytoplasm 
from the conversion of glucose in the media. Excess capacity for electron entry in the 
ubiquinone pool via NADH and F ADH2 was determined by uncoupling the 
synaptosomes in a step-wise manner with successive 1 µL injections of carbonyl cyanide-
p-trifluoromethoxyphenylhydrazone (0.5 µM, FCCP). Proton leak was measured after 
inhibiting the F oF 1 ATPase activity with the addition of oligomycin (2 µg/mL) in the 
absence ofFCCP. Non-mitochondrial oxygen consumption was recorded in the presence 
of antimycin A (2.5 µM). 
E. Permeabilized Synaptosome Respirometry 
Oxygen consumption of permeabilized synaptosomes was measured in 2 mL of 
MIR05 Medium (0.5 mM EGT A, 3 mM MgCh, 60 mM K-lactobionate, 20 mM taurine, 
10 mM KH2P04, 20 mM HEPES, 110 mM sucrose, l g/L BSA) at 37°C using Clark-type 
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polarographic electrodes. Mitochondrial bioenergetics of permeabilized synaptosomes 
was evaluated in all treatment groups under the same set of conditions. Synaptosomes 
were permeated with digitonin (8.1 mM). Proton leak fueled by Complex I was measured 
after the addition of 5 µL malate ( 400 mM, M), 10 µL glutamate (2000 mM, G), and 5 
µL pyruvate (2000 mM, P) in the absence of adenosine 5' diphosphate (ADP). Oxygen 
consumption under conditions of oxidative phosphorylation (OXPHOS) was measured 
after the addition of 5 µL ADP (500 mM) in the presence ofMGP. Contributions of 
Complex II to OXPHOS capacity was measured with the addition of20 µL succinate 
(1000 mM) in the presence of both MGP and ADP. Excess capacity for electron transfer 
produced by Complexes I & II was determined by uncoupling the synaptosomes in a 
step-wise manner with 1 µL injections of carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone (0.5 µM, FCCP). Proton leak fueled by Complexes I & 
II was measured by inhibiting the F oF 1 ATPase activity with the addition of oligomycin 
(final concentration 2 µg/mL) in the absence of FCCP and in the presence ofMGPDS. 
Non mitochondrial oxygen consumption was recorded in the presence of antimycin A 
(2.5 µM). 
F. Succinate Dehydrogenase Assay 
Succinate dehydrogenase activity in synaptosomal extracts was performed as 
described previously (Munujos et al., 1993). Briefly, 10 µL of isolated mitochondria was 
dissolved in 970 µL of the reaction mixture consisting oftriethanolamine (100 mM, pH 
8.3), EDTA (0.5 mM), NaCN (2 mM), iodonitrotetrazolium chloride (INT; 2 mM), and 
Kolliphor EL (12 g/L). The absorbance reading was set to zero and the assay was 
initiated through the addition of 20 µL of succinate (1 M). The change in absorbance 
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after the addition of succinate was recorded at room temperature every second for 6 
minutes at 500 nm using an Evolution 300 UV-VIS spectrophotometer (Fisher Scientific, 
Pittsburgh, PA). Succinate dehydrogenase activity was calculated from the initial linear 
increase in absorbance at 500 nm and expressed as absorbance per minute per µg of 
protein. 
G. Citrate Synthase Assay 
A citrate synthase assay was performed as described elsewhere (Childress and 
Somero, 1979). Briefly, 10 µL of isolated mitochondria was dissolved in 980 µL of the 
reaction mixture consisting of imidazole (pH 8.0; 50 mM), acetyl-CoA (0.1 mM), 5,5-
dithiobis(2-nitrobenzoic acid) (DTNB) (0.1 mM), and MgCh (1.5 mM). The absorbance 
reading was set to zero and the reaction was initiated through the addition of 10 µL of 
oxaloacetate (50 mM). The change in absorbance after the addition of oxaloacetate was 
recorded at room temperature every second for one minute at 412 nm using an Evolution 
300 UV-VIS spectrophotometer (Fisher Scientific, Pittsburgh, PA). Citrate synthase 
activity was calculated from the initial linear increase in absorbance at 412 nm and 
expressed as absorbance per minute per µg of protein. 
H. Western Blot 
Synaptosome samples were mixed at a 1 : 1 ratio with sample Laemmeli buffer 
(2% SDS, 25% glycerol, 5% mercaptoethanol, 0.01 % bromphenol blue, and 62,5 mM 
Tris-HCl, pH 6.8), denatured at 95°C for 5 min and 20 µL of extract was loaded per lane. 
Synaptosomal samples were subjected to 10% SDS-PAGE using Bio-Rad Mini-
PROTEAN precast gels (Bio-Rad Laboratories, Hercules, CA). The proteins in the gels 
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were electrophoretically transferred at 120 volts for l h in a transfer buffer containing 
192 mM glycine, 20% methanol, 0.025% SDS, and 25 mM Tris onto a nitrocellulose 
membrane. The membrane was washed with 25 mL of Tris-buffered saline containing 
0.05% Tween-20 (TBS-T), subsequently stained with Ponceus stain to confirm protein 
transfer, and the lanes were cut in a fashion to allow for 2 separate antibody incubations. 
The membrane was washed with TBS-T and blocked with 5% fat free dry milk in TBS-T 
for 1 h. After washing the membranes with TBS-T, rabbit anti-VDAC and rabbit anti-P-
tubulin (Cell Signaling Technologies, Beverly, MA) were used as primary antibodies at a 
1 :5,000 dilution. The blots were incubated in a 5% BSA-TBS-T solution with the primary 
antibodies overnight at 4 °C. Membranes were washed three times for 5 min each with 
TBST, and incubated with an HRP-labeled goat anti-rabbit secondary antibody for 1 hat 
room temperature. Membranes were washed three times for 5 min each with TBST and 
proteins were visualized using a chemiluminescence detection kit (Fujifilm, Tokyo, 
Japan). 
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III. Results 
A. ApoE KO versus WT Comparison 
1. Respirometry of Intact Synaptosomes 
Basal respiration of 3-6 month WT and apoE KO mice was measured in intact 
synaptosomes suspended in a medium containing glucose (Fig. IA). Basal respiration 
rates reflect mitochondrial respiration fueled by NADH and F ADH2 provided by the 
glycolytic and mitochondrial conversion of glucose supplied by the medium and 
converted to pyruvate in the cytoplasm of the nerve cell terminal to fuel the 
mitochondrial Krebs cycle (Choi et al. 2009) via pyruvate decarboxylation. Ovariectomy 
did not change respiration in wild-type or apoE KO mice. However, estrogen treatment in 
apoE KO significantly increased oxygen consumption compared to the Sham (p < 0.05). 
In order to assay the maximum respiratory capacity of non-permeabilized 
synaptosomes, the mitochondrial electron transport system (ETS) was uncoupled from 
the phosphorylation system with the addition ofFCCP (Fig. lB). The observed FCCP 
uncoupled respiration rates were 5-fold higher than basal respiration rates. Estrogen 
treatment did not affect uncoupled oxygen consumption rates in ovariectomized WT 
mice. Estrogen treatment in ovariectomized apoE KO mice significantly increased 
uncoupled respiration compared to Sham and estrogen treated WT (p < 0.05). 
Leak respiration was measured in the absence of FCCP after the addition of 
oligomycin (2 µg/mL) to block the FoF1-ATP synthase. Among the three assessed 
respiration parameters, leak respiration accounted for the lowest respiration rates 
measured (Fig. 1 C). Ovariectomy in apoE KO mice did not significantly alter respiration 
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compared to Sham. No differences in leak respiration were detected between sham and 
ovariectomized WT and apoE KO mice. Surprisingly, estrogen treated apoE KO mice 
had significantly higher respiration rates compared to estrogen treated WT mice. 
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Figure 1. Oxygen flux in intact synaptosomes from WT and apoE KO mice. 
Synaptosomes were isolated from either WT (white bar) or apoE KO (black bar) mice in 
the diestrous cycle (Sham OVX), following ovariectomy (OVX), or following treatment 
with 50 ng E2/g body weight (OVX + E2). (A) Basal respiration, (B) Uncoupled 
respiration, and (C) Leak respiration are shown. Respiration rates were standardized 
based on protein content and are expressed as pmol of 0 2 consumed per second per µg 
protein. Significant differences in oxygen flux are denoted with an asterisk (*). Data was 
analyzed using a two-way ANOVA (p < 0.05, n = 3-6). Data represent the mean± 
S.E.M. 
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2. Respirometry of Permeabilized Synaptosomes 
Respiration rates observed under permeabilized conditions in the presence of 
saturating substrate concentrations were approximately 10-fold higher than respiration 
rates of intact synaptosomes in presence of glucose alone (Figs. 1 and 2). Leak respiration 
driven by NADH in the absence of ADP was assayed after the addition ofMGP (malate, 
glutamate, and pyruvate) and no significant changes in the rate of oxygen consumption 
was observed in ovariectomized WT mice as compared to Sham (Fig. 2A). Despite the 
fact that estrogen treatment did not change leak respiration in WT mice, a significant 
increase in respiration rates was observed in apoE KO mice compared to estrogen treated 
WT mice (p < 0.05). Oxidative phosphorylation (OXPHOS) was initiated by the addition 
of0.5 M ADP. Neither ovariectomy nor estrogen treatment led to a change ofOXPHOS 
rates compared to the sham control in WT mice (Fig. 2B). Ovariectomy and subsequent 
estrogen treatment in apoE KO mice resulted in a significant increase in OXPHOS 
respiration as compared to Sham (p < 0.05). Furthermore, estrogen treated apoE KO mice 
had significantly higher OXPHOS rates compared to estrogen treated WT mice (p < 
0.05). 
Succinate was added to assess the simultaneous entry of electrons provided by 
complex II and complex I into the ubiquinone pool under OXPHOS conditions. 
Ovariectomy and estrogen treatment had no effect on respiration rates fueled by NADH 
and FADH2 (complex I+ II) supplying substrates in WT mice (Fig. 2C). In contrast to 
WT mice, ovariectomy in apoE KO mice resulted in significantly higher respiration rates 
measured under these conditions as compared to the Sham (p < 0.05). Estrogen treatment 
in apoE KO mice significantly increased respiration rates engaging complex I + II as 
14 
compared to the Sham, and estrogen treated WT mice (p < 0.05). Maximum respiratory 
capacities of the electron transport system (ETS) in permeabilized synaptosomes were 
examined after the addition ofFCCP (Fig. 2D). Similar to the results observed under 
OXPHOS conditions, estrogen treatment in apoE KO mice significantly increased 
uncoupled respiration as compared to the Sham (p < 0.05). In contrast, Sham and 
ovariectomized apoE KO and WT mice had similar uncoupled respiration rates. Leak 
respiration rates in the presence of ADP were examined by inhibiting the F0F1-ATPase 
with the addition of oligomycin. Both ovariectomy and estrogen treatment had no effect 
on respiration in WT mice. Likewise, ovariectomy in apoE KO had no effect on leak 
respiration rates, but estrogen treatment significantly increased leak respiration in apoE 
KO mice as compared to Sham. No significant differences in leak respiration were 
detected between apoE KO and WT. 
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Figure 2. Oxygen flux in permeabilized synaptosomes from WT and apoE KO mice. 
Synaptosomes were isolated from either WT (white bar) or apoE KO (black bar) mice in 
diestrous cycle (Sham OVX), following ovariectomy (OVX), or following treatment with 
16 
50 ng E2/g body weight (OVX + E2). (A) Leak respiration rates driven by MGP in the 
absence of ADP, (B) oxidative phosphorylation rates after the addition of ADP in 
presence of MGP, (C) response to addition of succinate under complex I fueled 
OXPHOS conditions, (D) uncoupled respiration in presence of the above mentioned 
substrate combination, and (E) leak respiration in the absence of FCCP after the addition 
of oligomycin to block the F0F1-ATP synthase. Respiration rates were standardized based 
on protein content and are expressed as pmol of 02 consumed per second per µg protein. 
Significant differences in oxygen flux are denoted with an asterisk (*). Data was analyzed 
using a two-way ANOV A (p < 0.05, n = 3-6). Data are presented as the mean± S.E.M. 
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3. Respirometry of Permeabilized Synaptosomes in Presence of Succinate and 
Roten one 
Next we examined F ADH2 fueled respiration alone in the presence of succinate 
and rotenone. Rotenone is a potent complex I inhibitor, which allowed for the assessment 
of complex II-derived electrons into the ubiquinone pool. Leak respiration was 
investigated after the addition of succinate and rotenone but in absence of ADP. No 
significant differences were detected between both phenotypes under sham conditions or 
after ovariectomy (Fig. 3a). Furthermore, estrogen treatment had no effect on leak 
respiration in WT mice but in apoE KO mice led to a significant increase in respiration 
rates compared to the Sham (p < 0.05). F ADH2 fueled rates of OXPHOS was assessed 
after the addition of ADP in the presence of rotenone and succinate (Fig. 3B). 
Ovariectomy or estrogen administration had no effect on respiration in WT mice, but in 
apoE KO both treatments led to significantly increased OXPHOS respiration rates 
compared to Sham (p < 0.05). These results were also reflected in the FCCP uncoupled 
respiration rates. Only in apoE KO ovariectomy and estrogen treatment led to significant 
increases in respiration but both treatments were without effect in wild type mice. 
However, maximum respiration rates did not exceed coupled OXPHOS rates for both 
WT and apoE KO mice (Fig. 3C). 
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Figure 3. Complex II fueled respiration in permeabilized synaptosomes from WT 
and apoE KO mice. Synaptosomes were isolated from either WT (white bar) or apoE 
KO (black bar) mice in the diestrous cycle (Sham), after ovariectomy (OVX), or OVX 
followed by treatment with 50 ng E2/g (Ovx + E2). (A) Leak respiration was assessed in 
the presence of rotenone and succinate. (B) Respiration under conditions of OXPHOS 
was initiated by addition of 3 mM ADP. (C) In order to uncouple oxygen utilization from 
ADP phosphorylation increments of 0.5 µM FCCP were added until maximum oxygen 
flux was observed. Respiration rates were standardized based on protein content and are 
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expressed as pmol of 02 consumed per second per µg protein. Significant differences in 
oxygen flux are denoted with an asterisk (*). Data was analyzed using a two-way 
ANOV A (p < 0.05, n = 3-6). Data are presented as the mean± S.E.M. 
4. Activity of Succinate Dehydrogenase and Citrate Synthase 
In order to evaluate whether increases in respiration rates observed in 
ovariectomized and estrogen treated WT or apoE KO mice were due to an increase in 
mitochondrial content per synaptosome, or an increase in the specific activity of 
respiratory complexes per mitochondrion, we investigated the activity of both succinate 
dehydrogenase (SDH; Fig. 4A) and citrate synthase (CS; Fig. 4B) in our preparation. 
Ovariectomized WT mice had a significant increase in SDH activity as compared to the 
Sham and estrogen treatment significantly reduced SDH activity in WT mice compared 
to the ovariectomy control (p < 0.05). Likewise, ovariectomy in apoE KO mice 
significantly increased SDH activity compared to the Sham, but estrogen treatment had 
no effect on SDH compared to the ovariectomy control. Furthermore, no significant 
differences in SDH activity were observed between apoE KO and WT mice under any 
condition. 
Citrate synthase (CS) activity is commonly used to judge mitochondrial content of 
cells (Remels et al., 2010). Neither ovariectomy nor estrogen treatment had any effect on 
CS activity in WT mice. Likewise, ovariectomy in apoE KO mice had no effect on CS 
activity but, interestingly, estrogen treatment nearly doubled CS activity in apoE KO 
mice compared to the Sham. Therefore, CS activity in apoE KO mice was highly 
sensitive to estrogen treatment whereas estrogen treatment in WT mice had no effect 
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Figure 4. Succinate dehydrogenase and citrate synthase activity in synaptosomes 
from WT and apoE KO mice. (A) Succinate dehydrogenase (SDH) activity and (B) 
citrate synthase (CS) activity were measured in synaptosome samples isolated from either 
WT (white bar) or apoE KO (black bar) mice in the diestrous cycle (Sham), after 
ovariectomy (OVX), or ovariectomy followed by treated with 50 ng E2/g (OVX + E2). 
SDH activity was standardized to total protein content and expressed as absorbance per 
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hour per milligram of total protein. CS activity was also standardized based on total 
protein and was expressed as absorbance per min per milligram of total protein. 
Significant differences in SDH and CS activity are denoted with asterisks (*). Data was 
analyzed using a two-way ANOV A (p < 0.05, n = 3-6). Data are presented as the mean± 
S.E.M. 
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5. Western Blot Analysis of the Voltage Dependant Anion Channel 
Immunoblotting of the voltage-dependent anion channel (VDAC) was used as an 
additional mitochondrial marker to further validate if the observed increases in SDH and 
CS activities were due to an increase in total number of mitochondria (Fig. SA). Relative 
to VDAC expression levels observed in sham, ovariectomy in WT mice resulted in a 26 
% increase in the level of the protein. Estrogen treatment in WT mice slightly decreased 
VDAC expression compared to the ovariectomy, but was still 21% higher than in Sham 
(Fig. SB). Similarly, ovariectomy significantly increased VDAC expression levels in 
apoE KO mice by 17% compared to the Sham, but in contrast to WT mice, estrogen 
treatment in apoE KO mice led to a further increase in VDAC expression reaching 29% 
above Sham (Fig. SB). 
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Figure 5. Immunoblotting of VDAC in WT and apoE KO mice. Synaptosome 
samples (20 µg total protein per lane) were subjected to SDS-P AGE and immunoblotted 
for VDAC. (A) Lane 1, molecular weight standards; lane 2, WT sham OVX; lane 3, WT 
OVX; lane 4, WT OVX + E2; lane 5, apoE KO sham OVX; lane 6, apoE KO OVX; lane 
7, apoE KO OVX + E2. (B). Optical density of VDAC bands were quantified using 
Image J software. WT mice (white bar); apoE KO (black bar). Values were converted to 
percent increase relative to the Sham. 
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B. Age Comparison: Old Mice versus Young Mice 
1. Intact Synaptosomes 
A comparison of basal respiration in young (3-6 month) and old (12-24 month) 
WT and apoE KO mice was measured in intact synaptosomes suspended in a medium 
containing glucose as the sole carbon source (Fig. 6A & 6B). Basal respiration rates 
reflect mitochondrial respiration fueled by NADH and F ADH2 provided by the glycolytic 
and mitochondrial conversion of glucose supplied by the medium and converted to 
pyruvate in the cytoplasm of the nerve cell terminal to fuel the mitochondrial Krebs cycle 
(Choi et al. 2009) via pyruvate decarboxylation. 
i. Respirometry of Intact Synaptosomes from Wild-Type Mice 
No differences in basal respiration were detected between young and old WT 
mice (Fig. 6A). Furthermore, ovariectomy and estrogen treatment had no effect on basal 
respiration in old mice. For a detailed comparison of treatment effects within young WT 
mice please refer to section III.A. I. In order to assay the maximum respiratory capacity 
of non-permeabilized synaptosomes, the mitochondrial electron transport system (ETS) 
was uncoupled from the phosphorylation system with the stepwise addition of FCCP 
(Fig. 6C). The observed uncoupled respiration rates were approximately 5-fold higher 
than basal respiration rates. Old WT Sham mice had significantly higher uncoupled 
respiration rates compared to the young Sham group (p < 0.05; Fig. 6C). No differences 
in the uncoupled respiration rates were detected after ovariectomy and subsequent 
estrogen treatment in old mice. Leak respiration was measured in the absence of FCCP 
after the addition of oligomycin (2 ~.tg/mL) to block the F oF 1-A TP synthase (Fig. 6E). 
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Among the three non-permeabilized respiration parameters, leak respiration accounted 
for the lowest respiration rates and no differences were detected between young and old 
mice (Fig. 6E). Furthermore, ovariectomy or ovariectomy followed by estrogen treatment 
had no effect on leak respiration in old mice. 
ii. Respirometry of Intact Synaptosomes from ApoE KO Mice 
Similar to the results observed in wild-type mice no differences in basal respiration were 
detected between young and old apoE KO mice (Fig. 6B). Furthermore, ovariectomy and 
estrogen treatment had no effect on basal respiration in old mice. For a detailed 
comparison of treatment effects within young apoE KO mice please refer to section 
III.A. I. Maximum respiratory capacity was again measured after the stepwise addition of 
FCCP), and respiration rates increased similar to the increase observed in WT mice (Fig. 
6D,C). Unlike Old WT Sham mice no significant increase in uncoupled respiration rates 
between young and old Sham apoE KO was observed (p > 0.05; Fig. 6D). A comparison 
among treatment groups revealed no differences in the uncoupled respiration rates after 
ovariectomy and subsequent estrogen treatment in old mice. As in WT mice leak 
respiration accounted for the lowest respiration rates and no differences were detected 
between young and old mice or among treatment groups (Fig. 6F). 
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Figure 6. Oxygen flux in intact synaptosomes from old and young WT and apoE KO 
mice. Synaptosomes were isolated from either young WT (white bar), old WT (black 
bar), young apoE KO (dark gray bar), or old apoE KO (light gray bar) mice in the 
diestrous cycle (Sham OVX), after ovariectomy (OVX), or after ovariectomy following 
by treatment with 50 ng E2/g (OVX + E2). (A & B) Basal respiration, (C & D) 
Uncoupled respiration, and (E & F) depicts leak respiration. Respiration rates were 
standardized based on protein content and are expressed as pmol of 02 consumed per 
second per µg protein. Significant differences in oxygen flux are denoted with an asterisk 
(*). Data was analyzed using a two-way ANOV A (p < 0.05, n = 3-6). Data are presented 
as the mean ± S.E.M. #young wild-type and ApoE KO are added for reasons of 
comparison and are from figures IA, B, C. 
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2. Respirometry of Permeabilized Synaptosomes 
The titration protocol used for permeabilized synaptosomes from old mice was 
the same as used for young mice. Briefly, leak respiration driven by NADH in the 
absence of ADP was assayed after the addition of MGP and OXPHOS was stimulated by 
addition of ADP. Succinate was added to assess any impact of electron entry provided by 
complex II and complex I into the ubiquinone pool and maximal respiration was recorded 
after uncoupling with FCCP. Again leak respiration was measured in presence of 
oligomycin. Across the parameters investigated, rates observed under permeabilized 
conditions were approximately 5 to 10-fold higher than respiration rates of intact 
synaptosomes in the presence of glucose alone. 
i. Respirometry of Permeabilized Synaptosomes from Wild-Type Mice 
Old WT Sham mice had significantly higher MGP induced leak respiration rates 
compared to the young Sham (p < 0.05; Fig. 7 A). Ovariectomy and subsequent estrogen 
treatment resulted in a significant reduction in leak respiration in old mice compared to 
its Sham (p < 0.05). OXPHOS rates for old WT Sham was significantly higher than 
those observed in the young WT Sham mice and neither ovariectomy nor estrogen 
treatment had any effect on rates in old mice compared to its Sham (p < 0.05; Fig. 7C). 
Respiration rates fueled by NADH and F ADH2 supplying substrates in old WT Sham 
mice was significantly higher than those rates observed in young WT mice. However, 
ovariectomy and estrogen treatment had no effect in old WT mice compared to its Sham 
on respiration rates (Fig. 7E). No age effects were observed on uncoupled respiration 
rates and all treatment groups displayed similar rates of oxygen consumption (Fig. 7G). 
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Proton leak in presence of oligomycin was significantly higher in old Sham mice 
compared to young Sham mice (p<0.05) and both ovariectomy and estrogen treatment 
resulted in a significant reduction in leak respiration in old WT mice (p < 0.05; Fig. 71). 
ii. Respirometry of Permeabilized Synaptosomes from ApoE KO Mice 
In contrast to WT mice old apoE KO Sham were not different from young ApoE 
KO Sham in MGP induced leak respiration rates. However, ovariectomized old apoE 
KO mice had significantly higher leak respiration compared to young ovariectomized 
mice and estrogen treatment did not rescue respiration rates in old mice (Fig. 7B). After 
induction of OXPHOS, respiration rates in old Sham mice were significantly higher than 
those observed in young Sham mice, but ovariectomy and estrogen treatment had no 
effect in old mice (Fig. 7D). As observed for wild-type mice under concurrent electron 
entry into the ubiquinone pool by NADH and F ADH2 supplying substrates old ApoE KO 
Sham rates were also significantly higher than those rates observed in the young age 
group. Again ovariectomy and estrogen treatment had no effect on respiration rates (p < 
0.05; Fig. 7F, E). Uncoupled respiration rates were similar between young and old mice 
and did not differ among treatment groups (Fig. 7H). Similar to the results observed in 
WT leak respiration rates were higher in old ApoE KO Sham than in young ApoE KO 
Sham but neither ovariectomy and estrogen impacted respiration rate in old ApoE KO 
(Fig. 70). 
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Figure 7. Oxygen flux in permeabilized synaptosomes from old and young WT and 
apoE KO mice. Synaptosomes were isolated from either young WT (white bar), old WT 
(black bar), young apoE KO (dark gray bar), or old apoE KO (light gray bar) mice in the 
diestrous cycle (Sham OVX), after ovariectomy (OVX), or ovariectomy followed by 
treatment with 50 ng E2/g (OVX + E2). (A & B) Leak respiration rates driven by MGP in 
the absence of ADP, (C & D) complex I and II OXPHOS rates after the addition of ADP, 
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(E & F) OXPHOS rates in the presence of succinate and MGP, (G & H) uncoupled 
respiration after the addition of FCCP, and (I & J) leak respiration after the addition of 
oligomycin. Respiration rates were standardized based on protein content and are 
expressed as pmol of 0 2 consumed per second per µg protein. Significant differences in 
oxygen flux are denoted with an asterisk (*). Data was analyzed using a two-way 
ANOV A (p < 0.05, n = 3-6). Data are presented as the mean ± S.E.M. #young wild-type 
and ApoE KO are added for reasons of comparison and are from figures 2A, B, C, D, E. 
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3. Respirometry of Permeabilized Synaptosomes in Presence of Succinate and 
Roten one 
Complex II respiration in permeabilized synaptosomes was assessed in a separate 
titration scheme. Briefly, Complex II fueled leak respiration and OXPHOS was 
investigated in the presence of rotenone, a potent complex I inhibitor (Fig. 8A & 8B). 
i. Respirometry of Permeabilized Synaptosomes from Wild-Type and ApoE 
KO Mice 
Old WT Sham mice had significantly higher complex II leak respiration rates in 
comparison to rates observed in young WT sham mice ( p< 0.05). Furthermore, 
ovariectomy and estrogen treatment resulted in a significant decrease in complex II leak 
respiration in old WT mice (p < 0.05; Fig. 8A). Similar to WT mice, old apoE KO Sham 
mice had significantly higher complex II leak respiration rates compared to the rates 
observed for young apoE KO mice. In contrast to old WT mice, ovariectomy and 
estrogen treatment in old apoE KO mice had no effect on complex II leak respiration. 
After addition of ADP to induce OXPHOS, old WT Sham mice had significantly higher 
complex II OXPHOS rates compared to young WT sham mice and rates were 
significantly reduced after ovariectomy and estrogen treatment in old WT mice (p < 0.05; 
Fig. 8C). However, no age effect in OXPHOS rates was observed in apoE KO mice and 
among treatment groups (Fig. 8D). Maximum respiration rates did not exceed coupled 
OXPHOS rates and were strikingly similar to rates generated in presence of succinate and 
ADP for both WT and apoE KO mice (Fig 8E,F). 
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Figure 8. Complex II analysis in permeabilized synaptosomes from old and young 
WT and apoE KO mice. Synaptosomes were isolated from either young WT (white 
bar), old WT (black bar), young apoE KO (dark gray bar), or old apoE KO (light gray 
bar) mice in the diestrous cycle (Sham OVX), after ovariectomy (OVX), or ovariectomy 
followed by treatment with 50 ng E2/g (OVX + E2). (A & B) Complex II driven leak 
respiration was assessed in the presence of rotenone and succinate. (C & D) OXPHOS 
respiration initiated after the addition of 3 mM ADP. (E & F) Oxygen utilization was 
uncoupled from ADP phosphorylation with the addition of 0.5 µM increments of FCCP 
until maximum oxygen flux was observed. Respiration rates were standardized based on 
protein content and are expressed as pmol of 0 2 consumed per second per µg protein. 
Significant differences in oxygen flux are denoted with an asterisk(*). Data was analyzed 
using a two-way ANOV A (p < 0.05, n = 3-6). Data are presented as the mean ± S.E.M. 
#young wild-type and ApoE KO are added for reasons of comparison and are from 
figures 3A, B, C. 
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4. Enzymatic Activity of Succinate Dehydrogenase and Citrate Synthase 
Respiration data was corroborated by investigating the activity of succinate 
dehydrogenase (SDH; Fig. 9A & 9B) and citrate synthase (CS; Fig. 9C & 9D). Old WT 
Sham mice had significantly higher SDH activity compared to young WT Sham mice 
(Fig. 9A; p < 0.05). SDH activity after ovariectomy and estrogen treated did not change 
in old WT mice. In contrast to WT mice, no age effects were observed on SDH activity in 
apoE KO mice. However, old ovariectomized and estrogen treated apoE KO mice had 
significantly higher SDH activity compared to its Sham. CS activity in old WT mice was 
the same as observed for young WT mice and no differences were observed among 
treatment groups in old mice (Fig 9C). In contrast to WT mice, old apoE KO Sham mice 
had significantly higher CS activity compared to the young Sham mice. However, as in 
WT ovariectomy and estrogen treatment in old apoE KO mice had no effect on CS 
activity (Fig. 9B; p < 0.05). 
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Figure 9. Succinate dehydrogenase and citrate synthase activity in synaptosomes 
from young and old WT and apoE KO mice. (A & B) Succinate dehydrogenase (SDH) 
activity and (C & D) citrate synthase (CS) activity were analyzed in synaptosome 
samples isolated from either young WT (white bar), old WT (black bar), young apoE KO 
(dark gray bar), or old apoE KO (light gray bar) mice in the diestrous cycle (Sham OVX), 
after ovariectomy (OVX), or ovariectomy followed by treatment with 50 ng E2/g (OVX 
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+ E2). SDH activity was standardized to total protein content and expressed as 
absorbance per h per milligram of total protein. CS activity was also standardized based 
on total protein and was expressed as absorbance per min per milligram of total protein. 
Significant differences in SDH and CS activity are denoted with asterisks (*). Data was 
analyzed using a two-way ANOVA (p < 0.05, n = 3-6). Data are presented as the mean± 
S.E.M. #young wild-type and ApoE KO are added for reasons of comparison and are 
from figures 4A & 4B. 
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5. Western Blot Analysis of the Voltage Dependant Anion Channel 
Expression levels of the voltage dependent anion channel (VDAC) were used as a 
mitochondrial marker to determine if increases in SDH and CS activities are contributed 
to an increase in total number of mitochondria (Fig. 10). Old WT Sham mice had 29% 
higher expression levels ofVDAC compared to the young Sham. Ovariectomy and 
estrogen treatment caused insignificant increases in VDAC expression in old WT mice by 
7% and 1 %, respectively, compared to ovariectomized and estrogen treated young WT 
mice. In contrast to WT mice, young apoE KO mice had higher VDAC expression levels 
compared to old apoE KO mice for sham and estrogen treated mice. Young apoE KO 
sham VDAC expression was 19% higher than old sham mice, whereas, young estrogen 
treated apoE KO mice had 6% higher VDAC expression compared to old mice. 
Interestingly, old ovariectomized apoE KO mice had a 6% higher expression ofVDAC 
compared to young ovariectomized mice. A detailed comparison of treatment groups 
within old mice revealed that relative to the Sham expression, ovariectomy in old WT 
mice resulted in a minor 4% increase in VDAC expression. Estrogen treatment decreased 
VDAC expression by 8% in old WT mice. Surprisingly, ovariectomy increased VDAC 
expression by over 36% in old apoE KO mice compared to levels observed in Sham. In 
striking contrast to WT mice, estrogen treatment in apoE KO mice led to a further 
increase in VDAC levels by 38% compared to the Sham. 
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Figure 10. Immunoblotting of VDAC in young and old WT and apoE KO mice. 
Synaptosome samples (20 µg total protein per lane) were subjected to SDS-PAGE and 
immunoblotted for VDAC. (A) Old and young WT mice; Lane 1 = molecular weight 
standards, lane 2 =WT sham OVX, lane 3 =WT OVX, lane 4 =WT OVX + E2, lane 5 = 
old WT sham OVX, lane 6 = old WT OVX, lane 7 = old WT OVX + E2. (B). Old and 
young apoE KO mice; Lane 1 = molecular weight standards, lane 2 = apoE KO sham 
OVX, lane 3 = apoE KO OVX, lane 4 = apoE KO OVX + E2; lane 5 = old apoE KO 
OVX, lane 6 = old apoE KO OVX; lane 7 = old apoE KO OVX + E2. Optical density of 
VDAC bands were quantified using Image J software. 
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IV. Discussion 
It is well known that the inheritance of the apoe4 allele increases the likelihood of 
sporadic and late-onset familial AD (Corder et al. 1993; Bullido et al. 1998; Mahley et 
al., 2006). Expression of the apoe4 allele has also been shown to drastically lower apoE 
concentrations in the brain (Poirier et al., 1995), as well as, decrease brain mitochondrial 
enzymatic activities (Risner et al., 2006). In addition, decreases in glucose utilization and 
mitochondrial dysfunctions have been observed before the pathological onset of AD in 
patients predisposed by apoe4 inheritance (Reiman et al., 1996; Lin and Beal, 2006). In 
light of these key findings, we chose to use apoE KO mice as our experimental AD 
model in order to better our understandings of the effects of apoE on mitochondrial 
respiration and on enzymatic function in synaptosomes. 
A. Synaptosomal Respiration: The Effect of ApoE 
High-resolution respirometry of intact synaptosomes from apoE KO Sham and 
ovariectomized mice revealed no significant differences when compared with WT Sham 
and ovariectomized mice (Figure 1 ). However, estrogen treated apoE KO mice had 
significantly higher basal, uncoupled, and leak respiration in intact synaptosomes 
compared to age matched WT mice; a trend that extended into oxygen consumption rates 
of permeabilized synaptosomes (Figures 1 & 2). Our results indicate that apoE KO and 
WT mice have approximately the same capacity for glucose transportation and utilization 
under sham and ovariectomized conditions, since no differences were detected in 
mitochondrial oxygen consumption. Previous studies have demonstrated that 1 7~­
estradiol up-regulates glucose transporter proteins in the neurons of non-human primates 
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(Shi et al., 1997; Cheng et al., 2001 ). Therefore, increases in intact respiration were 
expected after the administration of estrogen; however, only apoE KO mice revealed 
increased respiration in intact synaptosomes, whereas, no effect was observed in WT 
mice (Figure 1 ). In addition, respiration rates in permeabilized synaptosomes were also 
significantly higher in estrogen treated apoE KO mice compared to its sham control, as 
well as, in age matched estrogen treated WT mice, whereas estrogen treatment had no 
effect in WT mice (Figures 2 & 7). In order to further understand this trend, enzymatic 
analysis of SDH and CS was conducted and revealed significantly higher enzymatic 
activities in estrogen treated apoE KO mice, whereas no effect was observed in estrogen 
treated WT mice (Figure 4). In light of these key findings, we concluded that increases in 
respiration were due to increases in mitochondria quantity via mitochondrial biogenesis, 
which was further validated via a Western Blot using VDAC as a mitochondrial 
housekeeping marker (Figure 5). In addition, we speculate that the protein apoE plays a 
regulatory role in estrogen induced mitochondrial biogenesis, thus explaining the 
differences observed between genotypes. 
B. Mitochondrial Biogenesis 
Mitochondrial biogenesis is a highly integrated process that requires immense 
coordination between nuclear and mitochondrial gene products including NRF-1, NRF-2, 
Tfam, PGC-la, and mortalin (Kelly and Scarpulla, 2004; Londono et al., 2012). In 
particular, PGC-1 a has been considered the master regulator for mitochondrial biogenesis 
in mammals, and is responsible for the activation of the required transcription factors 
needed for the initiation of mitochondrial biogenesis (Ventura-Clapier et al., 2008; Wu et 
al., 1999). Previous studies have shown that 17~-estradiol, as well as, oxidative stress 
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increase mRNA and protein levels of PGC-lu (Hsieh et al., 2005; Lee and Wei, 2005). It 
is also well known that aging increases mitochondrial driven oxidative stress (Berlett and 
Stadtman, 1997; Kokoszka, 2001; Lin and Beal, 2006), thereby increasing PGC-1 a 
expression which explains the increases in synaptosome respiration observed in old mice 
when compared to their younger counterpart (Figure 6, 7 & 8). Currently there is no 
evidence suggesting that PGC-la is differentially regulated in WT and apoE KO mice via 
estrogen treatment and/or under oxidative stress. However, mitochondrial biogenesis 
relies heavily on the import of proteins from the cytosol via mitochondrial-specific 
translocase proteins like mortalin (Koehler, 2004). Mortalin is a mitochondrial heat shock 
protein that is associated with the voltage dependent anion channel (VDAC) and plays a 
vital role in mitochondrial biogenesis, cell proliferation, and oxidative stress (Londono et 
al., 2012; Kaul et al., 1993; Wadhwa et al., 1993a). Interestingly, mortalin has a substrate 
binding domain that has been shown to bind with apoE in vivo, however, the function of 
this interaction is unknown (Londono et al., 2012). We propose that the mortalin-apoE 
interaction has an inhibitory effect on mitochondrial biogenesis by preventing the 
translocation of PGC-la induced cytosolic proteins into the mitochondrion. Therefore, 
mice lacking apoE have increased mitochondrial biogenesis through the combined efforts 
of mortalin and PGC-1 a in comparison to WT mice. 
C. Antioxidant Defense Mechanisms 
Another interesting result observed in our study was that ovariectomy surgery 
induced higher respiratory rates, as well as enzymatic activity, in both WT and apoE KO 
mice (Figures 2, 3, 4, 7 and 9). It is well known that mitochondria are the main source of 
ROS during metabolism (Chen et al., 2003). Mitochondria have enzymatic defense 
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systems in place to combat ROS production, such as, superoxide dismutase and 
glutathione peroxidase. Previous studies have shown that removal of ovaries drastically 
lowers expression levels of superoxide dismutase in mitochondrial fractions, thus 
increasing the amount of ROS exposure over time on the cellular level (Ha, 2004; Borras 
et al., 2003). Furthermore, increases in ROS production have been linked to increases in 
mitochondrial quantity (Barrientos et al., 1997a; Lee et al., 2002), which has been 
speculated to play a compensatory role for defective mitochondria (Lee and Wei, 2000). 
Our results, specifically increases in respiration observed in ovariectomized mice under 
permeabilized conditions, support the phenomenon of ROS induced mitochondrial 
biogenesis. In addition, Western blot analysis revealed increased expression levels of 
VDAC and increased enzymatic activity of complex II and the Krebs cycle in 
ovariectomized mice compared to the Shams, which provides substantial evidence that 
mitochondrial quantity was increased (Figures 5 and I 0). 
D. Estrogen 
Estrogen's mechanism of action mediates targeted protein synthesis, including 
superoxide dismutase (Stirone et al., 2005b ), which reduces ROS exposure. 
Ovariectomized WT mice injected with estrogen revealed oxygen consumption levels 
that resembled its Sham (Figures 1, 2, and 3). This was an expected result since estrogen 
most likely increased expression levels of antioxidant enzymes, such as superoxide 
dismutase, but an immunoblot would be needed to confirm this hypothesis. However, in 
most cases a single injection of estrogen was insufficient to bring oxygen fluxes all the 
way back to sham levels indicating a need for multiple estrogen injection to induce 
significant affects on mitochondrial activity. In contrast to WT mice, estrogen treated 
45 
apoE KO mice had significantly higher respiration rates and enzymatic activity compared 
to age matched WT mice (Figures 1, 2, 3, and 4). Previous studies have shown that 
synaptosomes isolated from apoE KO mice are structurally different from WT mice 
(Keller et al., 2000; Lauderback et al., 2001). Specifically, apoE KO synaptosomes 
possess increased membrane bilayer fluidity as a result of increases in oxidation of 
cholesterol (Maor et al., 2000). It is possible that increases in bilayer fluidity may 
increase synaptosomal uptake of estrogen, thereby increasing the activity of 
mitochondrial targeted estrogen-receptors, thus providing another explanation for 
estrogen induced increases in respiration and enzymatic activity observed in apoE KO 
mice compared to WT mice. In addition, increases in membrane fluidity are associated 
with increases in macromolecule interactions with receptors (Lenaz, 1987). As a result, 
estrogen induced signal transduction in apoE KO mice may be more active compared to 
WT mice. 
Estrogen treatment had little to no effect in old mice (Figures 6, 7, and 8). 
Previous studies have shown that increases in rodent age are associated with decreases in 
estrogen receptors located in synapses (Adams et al., 2002). In light of this finding, it is 
not unreasonable to assume that the response to estrogen in aged mice will be blunted for 
all respiration parameters and enzymatic activities. However, the standard errors reported 
for old mice were relatively high compared with young mice, so the effects of estrogen 
may have been concealed. This may indicate that age plays a larger role in synaptosomal 
respiration and in order to reduce error in future studies the age range may need to be 
narrowed. 
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V. Conclusions 
The conclusions of this thesis can be summarized in five key points: 
1. Sham and ovariectomized young WT and apoE KO mice had similar respiration rates 
for intact and permeabilized synaptosomes, as well as, similar enzymatic activity. 
2. Estrogen treatment dramatically increased respiration in intact and permeabilized 
synaptosomes, and enzymatic activity in young apoE KO mice, whereas, no effect was 
observed in young WT mice. Additionally, estrogen treatment had no effect in old mice 
from both genotypes. 
3. Overall, age had little effect on respiration rates observed in intact synaptosomes, but 
significant increases in old WT and apoE KO Sham mice, compared to their younger 
counterparts, were detected for all permeabilized parameters except for uncoupled 
respiration. 
4. Interestingly, ovariectomy and estrogen treatment increased VDAC expression in 
young and old apoE KO mice. However, VDAC expression in young WT mice were 
remarkably similar among treatment groups, whereas, slight decreases were observed in 
old ovariectomized and estrogen treated WT mice, in comparison to the Sham control. 
5. We speculate that the observed increases in respiration and enzymatic activity are due 
to increases in mitochondrial quantity, which was supported via our VDAC expression 
data. We propose that mitochondrial biogenesis was stimulated through a concerted effort 
of translocating PGC-1 a induced proteins via estrogen by mortalin. We are also 
suggesting that apoE plays a regulatory role on mortalin's translocating ability thus 
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explaining the differences observed between apoE KO and WT mice. In addition, it is 
most likely that increases in respiration from old mice was due to ROS induced 
mitochondrial biogenesis and the abolished effects of estrogen in old mice was most 
likely due to decreases in estrogen receptor expression. 
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